[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-563836-105":53,"doc-detail-563836-en":120},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":113,"head_meta":115,"extra_data":117,"updated_unix":119},105,"en","well-woman-chart-2025","Well-Woman Chart 2025","","Well-Woman Chart 2025 compiles preventive care guidance and screening criteria for women, organized by clinical topics and include concise thresholds for when and whom to screen. It lists selected recommendations for diabetes, folic acid supplementation, diet and physical activity counseling, lipid and osteoporosis screening, and preventive medication such as statins for cardiovascular risk reduction. The chart also covers cancer screening approaches, infectious disease testing, STI and HIV prevention counseling, PrEP eligibility factors, immunization follow-through, and other risk-based interventions.",{"@graph":63,"@context":112},[64,80,95],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":36,"@type":70,"position":76},"https://docshare.wps.com/template/forms/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/well-woman-chart-2025/563836/",4,{"url":78,"name":59,"@type":81,"author":82,"headline":59,"publisher":85,"fileFormat":88,"inLanguage":57,"description":61,"dateModified":89,"datePublished":89,"encodingFormat":88,"isAccessibleForFree":90,"interactionStatistic":91},"DigitalDocument",{"name":83,"@type":84},"mieayamfan","Person",{"url":68,"name":86,"@type":87},"DocShare","Organization","application/pdf","2026-10-12",true,{"@type":92,"interactionType":93,"userInteractionCount":4},"InteractionCounter",{"@type":94},"ViewAction",{"@type":96,"mainEntity":97},"FAQPage",[98,104,108],{"name":99,"@type":100,"acceptedAnswer":101},"What screening criteria are provided for diabetes in women?","Question",{"text":102,"@type":103},"Screen women with overweight or obese BMI ages 35 to 70 years, and screen women ages 13 and older with prior gestational diabetes who have not been previously diagnosed with type 2 diabetes when not pregnant.","Answer",{"name":105,"@type":100,"acceptedAnswer":106},"Who may be eligible for HIV preexposure prophylaxis (PrEP) according to the chart?",{"text":107,"@type":103},"Candidates include heterosexually active women with an HIV-positive partner, women with inconsistent or no condom use with a partner whose HIV status is unknown and high risk, women with certain recent STIs, women using injection drugs or with an HIV-positive drug-injecting partner, and those engaged in transactional sex.",{"name":109,"@type":100,"acceptedAnswer":110},"What are the key criteria for breast and lung cancer screening?",{"text":111,"@type":103},"Breast cancer screening applies to women age 40 and older at average risk, with initiation and interval based on individual factors. Lung cancer screening is recommended for those with a 20 pack-year smoking history who currently smoke or quit within the past 15 years.","https://schema.org",{"og:url":78,"og:type":114,"og:title":59,"og:site_name":86,"og:description":61},"article",{"robots":116,"canonical":78},"index,follow",{"doc_id":118,"site_id":56},563836,1791838855,{"code":4,"msg":5,"data":121},{"doc_id":118,"user_id":122,"nickname":83,"user_avatar":123,"doc_module":9,"category_id":35,"category_name":36,"doc_title":59,"doc_description":61,"doc_content":124,"file_id":125,"file_url":126,"file_type":127,"file_size":128,"view_count":4,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":73,"language":129,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":130,"faqs":131,"seo_title":132,"seo_description":61,"update_tm":119,"read_time":9},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Abbreviations  \nBRCA1/2 = breast cancer susceptibility genes; CVD = cardiovascular disease; HIV = human immunodeficiency virus; HCV = hepatitis C virus; HBV = hepatitis B virus; STI = sexually transmitted infection; USPSTF = U.S. Preventive Services Task Force; WPSI = Women’s Preventive Services Initiative.  \n1Additional Bright Futures recommendations include: Periodic vision and hearing tests ages 13 to 21; screening for suicide risk ages 13 to 21; risk assessment for sudden cardiac arrest and sudden cardiac death ages 13 to 21; risk assessment for anemia ages 13 to 21; and fluoride supplementation if needed ages 13 to 16. ([https://downloads.aap.org/AAP/PDF/periodicity_schedule.pdf](https://downloads.aap.org/AAP/PDF/periodicity_schedule.pdf)). Accessed November 14, 2024. Criteria for selective screening  \n2 Diabetes screening: Screen women with overweight or obese BMI ages 35 to 70 years; and women ages ≥13 years with previous gestational diabetes but not previously diagnosed with type 2 diabetes when not pregnant.  \n3 Folic acid supplementation: Sexually active and planning or capable of pregnancy.  \n4 Healthy diet and physical activity counseling: Overweight or obese BMI and additional CVD risk factors (hypertension, dyslipidemia, abnormal blood glucose levels, diabetes).  \n5 Lipid screening: Lipid testing is needed to calculate 10-year CVD risk in adults. Screen adolescents ages 13 to 17 years with familial dyslipidemia, risk factors, or high-risk conditions.  \n6 Osteoporosis screening: 10-year fracture risk equivalent to an average-risk 65-year-old woman based on specific risk factors (parental history of hip fracture, smoking, excess alcohol consumption, low body weight).  \n7 Statin use to prevent CVD: Ages 40 to 75 years, one or more CVD risk factors (i.e., dyslipidemia, diabetes, hypertension, or smoking), and calculated 10-year risk of a CVD event ≥10%.  \n8 Urinary incontinence screening: Screen all women ages ≥18 and younger women if postpartum.  \n9 Chlamydia and gonorrhea screening: New sex partner, more than one sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; inconsistent condom use if not in mutually monogamous relationships; previous or coexisting STI; and exchanging sex for money or drugs. Prevalence is also higher among incarcerated populations, military recruits, and patients receiving care at public STI clinics.  \n10 Hepatitis B screening: Born in a country with a prevalence of HBV infection ≥2%; lack of vaccination in infancy if U.S.-born with parents from a country or region with prevalence ≥8%; HIV-positive; injection drug use; and household contacts or sexual partners of with HBV infection.  \n11 Hepatitis C screening: One-time screening for asymptomatic adults ages 18 to 79 without known liver disease. Repeat screening and screen at other ages if past or current injection drug use.  \n12 HIV preexposure prophylaxis (PrEP): Candidates include 1) heterosexually active women with a sexual partner who has HIV; or inconsistent or no use of condoms during sex with a partner whose HIV status is unknown and who is at high risk; or an STI with syphilis or gonorrhea within the past 6 months; 2) uses injection drugs and shared use of drug injection equipment; or has a drug-injecting partner who has HIV; 3) engaged in transactional sex, such as for money, drugs, or other.  \n13 Immunizations should be administered according to the most recent Advisory Committee on Immunization Practices (ACIP) recommendations ([https://www.cdc.gov/vaccines/imz-schedules/index.html](https://www.cdc.gov/vaccines/imz-schedules/index.html)). Accessed November 14, 2024.  \n14 Sexually transmitted infection prevention counseling: Risk factors for STIs include having an STI currently or within the past year, not consistently using condoms, having multiple sex partners, or having sex partners within populations with a high prevalence of STIs. Increased STI prevalence rates are found among women seeking STI","cbCaiiWUUHPFpIh8","https://ap.wps.com/l/cbCaiiWUUHPFpIh8","pdf",2111385,"English","# Abbreviations\n# Selected Screening Criteria\n## Diabetes screening\n## Folic acid supplementation\n## Healthy diet and physical activity counseling\n## Lipid screening\n## Osteoporosis screening\n## Statin use to prevent CVD\n## Urinary incontinence screening\n## Chlamydia and gonorrhea screening\n## Hepatitis B screening\n## Hepatitis C screening\n## HIV PrEP (preexposure prophylaxis)\n## Immunizations\n## STI prevention counseling\n## Syphilis screening\n## Tuberculosis infection\n## Breast cancer screening\n## Lung cancer screening\n## Medications to reduce breast cancer risk\n## Skin cancer counseling\n## Perinatal depression preventive interventions","[{\"question\":\"What screening criteria are provided for diabetes in women?\",\"answer\":\"Screen women with overweight or obese BMI ages 35 to 70 years, and screen women ages 13 and older with prior gestational diabetes who have not been previously diagnosed with type 2 diabetes when not pregnant.\"},{\"question\":\"Who may be eligible for HIV preexposure prophylaxis (PrEP) according to the chart?\",\"answer\":\"Candidates include heterosexually active women with an HIV-positive partner, women with inconsistent or no condom use with a partner whose HIV status is unknown and high risk, women with certain recent STIs, women using injection drugs or with an HIV-positive drug-injecting partner, and those engaged in transactional sex.\"},{\"question\":\"What are the key criteria for breast and lung cancer screening?\",\"answer\":\"Breast cancer screening applies to women age 40 and older at average risk, with initiation and interval based on individual factors. Lung cancer screening is recommended for those with a 20 pack-year smoking history who currently smoke or quit within the past 15 years.\"}]","Well-Woman Chart 2025 | PDF"]